Related Experiment Video
Updated: Sep 19, 2025

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Conduction Disorders After Transcatheter Aortic Valve Implantation: Evolution Over Time and Association With
Aileen Paula Chua1, Rinchyenkhand Myagmardorj1, Takeru Nabeta1
1Department of Cardiology, Heart Lung Center, Leiden University Medical Center, Leiden, The Netherlands.
Transcatheter aortic valve implantation (TAVI) can cause conduction abnormalities (CA). Patients needing a permanent pacemaker (PPM) after TAVI face higher long-term mortality and impaired left ventricular function.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Electrophysiology
Background:
- Transcatheter aortic valve implantation (TAVI) indications are expanding.
- New conduction abnormalities (CA), such as left bundle branch block (LBBB) or permanent pacemaker (PPM) implantation, are significant TAVI complications.
- Limited data exist on the long-term outcomes of post-TAVI CA.
Purpose of the Study:
- To investigate the progression of CA within the first year post-TAVI.
- To evaluate the long-term prognostic value of these CA.
- To assess the impact of CA on left ventricular function and all-cause mortality.
Main Methods:
- Categorized TAVI patients into: PPM implantation within 1 year, persistent LBBB at 1 year (permanent LBBB), or no CA.
- Assessed all-cause mortality as the primary endpoint.
- Collected data on baseline characteristics, valve type, left ventricular ejection fraction, global longitudinal strain, and long-term survival.
Main Results:
- 30% developed new LBBB, 17% had persistent LBBB, and 12% required PPM during hospitalization.
- At 1 year, PPM and permanent LBBB groups showed reduced left ventricular ejection fraction and global longitudinal strain compared to the no-CA group.
- Long-term follow-up (median 4 years) revealed higher all-cause mortality in the PPM group (p=0.006).
Conclusions:
- Post-TAVI CA exhibit dynamic changes within the first year.
- Patients requiring PPM after TAVI demonstrate poorer long-term outcomes and impaired left ventricular function.
- PPM implantation and reduced global longitudinal strain are independent predictors of mortality post-TAVI.
More Related Videos
06:02Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
04:30Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Related Concept Videos
Aortic Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation III: Medical Management
Mitral Stenosis I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation I: Introduction